Home > News > At IBM Research, a constant quest for the bleeding edge
August 2nd, 2010
At IBM Research, a constant quest for the bleeding edge
Abstract:
IBM also offers its customers and clients--and potential partners--one of its most intangible advantages, Frase said: the endless possibilities that come from having world-class researchers from wildly diverse disciplines working in close proximity.
An example of that power came, Frase explained, from the hallway conversations between an IBM Research "chip guy" and a "computational biology guy" who began talking about ideas of how they could work together.
"We're very much steered by what we see as the pain points of clients," Frase said, explaining that a new project with pharmaceutical giant Roche came from the discussions between the two researchers into whether it was possible to apply the company's expertise in microelectronics toward inexpensive gene sequencing.
The two researchers pondered the question and came up with a procedure in which they drilled a tiny hole into a microprocessor in order to allow a strand of DNA to go through and impact its nanocircuitry. By designing the circuitry of a chip to read peptide pairs, she explained, it is now theoretically possible to have a physical device that can get the cost of sequencing genes down to under $1,000. Roche saw the papers that the two researchers wrote on their work and came to IBM, and a partnership was born. Now, Roche will likely license the technology and bring it to market.
Source:
cnet.com
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
Research partnerships
Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||